SEHA, a subsidiary of PureHealth, the Middle East’s largest healthcare group, has highlighted the progress of an eight-year-old girl at SEHA’s Tawam Hospital who was treated for severe drug-resistant epilepsy (DRE), which had caused over 100 seizures per day and had a significant impact on her development and quality of life.
Despite getting anti-seizure medication, the patient continued to have regular seizures, which posed a significant strain on her daily life and on her family. The frequency of the episodes hampered her capacity to participate safely in regular children activities, necessitating a professional evaluation by SEHA’s Tawam Hospital paediatric neurology team.
The clinical team performed a thorough examination, including electroencephalography (EEG), magnetic resonance imaging, and genetic testing, to better understand the nature of the seizures and create a customised treatment approach. Following the assessment, the team optimised the patient’s pharmaceutical regimen and looked into other possibilities for epilepsy that had not responded well to medicine alone.
The patient had a vagus nerve stimulation (VNS) device implanted as part of his treatment regimen. VNS is an adjuvant treatment that sends frequent moderate electrical impulses to the vagus nerve, which may help reduce seizure frequency and severity in some individuals with drug-resistant epilepsy.
Also Read:
Attending the UAE-France Business Dialogue are Sheikh Khaled and Emmanuel Macron
The World’s sole UNESCO Chair in Arabic, AI, and Digital Heritage will be Hosted by Australia
About Author
